Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters

International Journal of Bipolar Disorders

Volumn 5, Issue 1, 2017, Pages

  Tondo, Leonardo ^a,b,c   Abramowicz, Maria ^d   Alda, Martin ^e   Bauer, Michael ^f   Bocchetta, Alberto ^g,h   Bolzani, Lorenza ⁱ   Calkin, Cynthia V ^e   Chillotti, Caterina ^h   Hidalgo Mazzei, Diego ^j   Manchia, Mirko ^e,g   Müller Oerlinghausen, Bruno ^k   Murru, Andrea ^j   Perugi, Giulio ^l   Pinna, Marco ^c,m   Quaranta, Giuseppe ^l   Reginaldi, Daniela ^c   Reif, Andreas ⁿ   Ritter, Philipp ^f   Rybakowski, Janusz K ^d   Saiger, David ^k   Sani, Gabriele ^p   Selle, Valerio ^a,i   Stamm, Thomas ^k,o   Vázquez, Gustavo H ^b,q,r   Veeh, Julia ⁿ   Vieta, Eduard ^j   Baldessarini, Ross J ^a,b   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c Lucio Bini Mood Disorders Center   (Italy)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g UNIVERSITY OF CAGLIARI   (Italy)

^h DEPARTMENT OF RADIOLOGY   (Italy)

ⁱ Viarnetto Psychiatric Clinic   (Switzerland)

^j UNIVERSITY OF BARCELONA   (Spain)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l UNIVERSITY OF PISA   (Italy)

^m UNIVERSITY OF PADOVA   (Italy)

ⁿ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^o BRANDENBURG MEDICAL SCHOOL THEODOR FONTANE   (Germany)

^p SAPIENZA UNIVERSITY OF ROME   (Italy)

^q QUEEN S UNIVERSITY   (Canada)

^r UNIVERSITY OF PALERMO   (Argentina)

more..

Author keywords

Blood urea nitrogen; Body mass index; Creatinine; eGFR; Glomerular filtration rate; Glucose; Lithium; Staging of renal function; White blood cell count

Indexed keywords

LITHIUM CARBONATE;

ANALYSIS OF VARIANCE; ARTICLE; BIPOLAR DISORDER; BODY MASS; COMORBIDITY; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DSM-IV; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LITHIUM BLOOD LEVEL; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

EID: 85044283634     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/s40345-017-0096-2     Document Type: Article

References (62)

1. Aiff H, Attman PO, Aurell M, Bendz H, Schön S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014;24:540–4.
2. Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015;29:608–14.
3. Albrecht J, Kampf D, Müller-Oerlinghausen B. Renal function and biopsy in patients on lithium therapy. Pharmacopsychiatry Neuropsychopharmacol. 1980;13:228–34.
4. Alsady M, Baumgarten R, Deen PM, de Groot T. Lithium in the kidney: friend and foe? J Am Soc Nephrol. 2016;27:1587–95.
5. American National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1–266.
6. American National Kidney Foundation, NKF. Frequently asked questions about GFR estimates; 2014. www.kidney.org/sites/default/files/docs/12-10-4004_abe_figs_aboutgfrrev1b_singleb.pdf. Accessed 10 Sept 2016.
7. Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M, et al. Long-term, low-dose lithium treatment does not impair renal function in the elderly: 2-year randomized, placebo-controlled trial followed by single-blind extension. J Clin Psychiatry. 2014;75:e672–8.
8. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology. 2002;46:67–9.
9. Azab AN, Shnaider A, Osher Y, Wang D, Bersudsky Y, Belmaker RH. Lithium nephrotoxicity. Int J Bipolar Disord. 2015;3:13.
10. Baldessarini RJ. Chemotherapy in Psychiatry. 2nd ed. New York: Springer Press; 2013.
11. Baldessarini RJ, Tondo L. Are renal tumors associated with lithium treatment? Int J Bipolar Disord. 2014;2:6.
12. Bauer M, Gitlin M. The essential guide to lithium treatment. Cham: Springer Press; 2016.
13. Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry: the comprehensive guide. Abingdon: Informa Press; 2006.
14. Bendz H. Kidney function in a selected lithium population. A prospective, controlled, lithium-withdrawal study. Acta Psychiatr Scand. 1985;72:451–63.
15. Bendz H, Schön S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77:219–24.
16. Bendz H, Sjödin I, Aurell A. Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study. Nephrol Dial Transpl. 1996;11:457–60.
17. Bocchetta A, Ardau R, Carta P, Ligas F, Sardu C, Pani A, Del Zompo M. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33.
18. Bocchetta A, Ardau R, Fanni T, Sardu C, Piras D, Pani A, Del Zompo M. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med. 2015;13:12.
19. Bocchetta A, Sardu C, Piras D, Pani A (2016) Long-term lithium and estimated glomerular filtration rate. Lancet Psychiatry 3(2):105-106
20. Calkin C, van de Velde C, Růzicková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord. 2009;11:650–6.
21. Carter L, Zolezzi M, Lewxzyk A. An updated review of the optimal lithium dosage regimen for renal protection. Can J Psychiatry. 2013;58:595–600.
22. Castro VM, Roberson AM, McCoy TH, Wiste A, Cagan A, Smoller JW, et al. Stratifying risk for renal insufficiency among lithium-treated patients: electronic health record study. Neuropsychopharmacology. 2016;41:1138–43.
23. Clos S, Rauchhaus P, Severn A, Cochrane L, Donnan PT. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study. Lancet Psychiatry. 2015;2:1075–83.
24. Close H, Reilly J, Mason JM, Kripalani M, Wilson D, Main J, Hungin AP. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS ONE. 2014;9:e90169.
25. Coşkunol H, Vahip S, Mees ED, Başçi A, Bayindir O, Tuğlulaŕ I. Renal side-effects of long-term lithium treatment. J Affect Disord. 1997;43:5–10.
26. Davis JM, Rosenbaum A, Shahinian V, Brosius FC. Prevention of lithium-associated renal failure: recent evidence. Lancet Psychiatry. 2015;2:1045–7.
27. Depaulo JR Jr, Correa EI, Sapir DG. Renal glomerular function and long-term lithium therapy. Am J Psychiatry. 1981;138:324–7.
28. Farshchian N, Farnia V, Aghaiani MR, Abdoli N. MRI findings and renal function in patients on lithium therapy. Curr Drug Saf. 2013;8:257–60.
29. Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study. PLoS Med. 2016;13:e100205.
30. Hullin RP, Coley VP, Birch NJ, Thomas TH, Morgan DB. Renal function after long-term treatment with lithium. Br Med J. 1979;1:1457–79.
31. Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med. 2014;161:242–8.
32. Jończyk-Potoczna K, Abramowicz M, Chłopocka-Woźniak M, Strzelczuk-Judka L, Michalak M, Czekalski S, Rybakowski JK. Renal sonography in bipolar patients on long-term lithium treatment. J Clin Ultrasound. 2016;44:354–9.
33. Karaosmanoglu AD, Butros SR, Arellano R (2013) Imaging findings of renal toxicity in patients on chronic lithium therapy. Diagn Interv Radiol 19(4):299–303
34. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study. JAMA Psychiatry. 2015;72:1182–91.
35. Kirkham E, Skinner J, Anderson T, Bazire S, Twigg MJ, Desborough JA. One lithium level >1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database. BMJ Open. 2014;4:020.
36. Kusalic M, Engelsmann F. Renal reactions to changes of lithium dosage. Neuropsychobiology. 1996;34:113–6.
37. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
38. Licht RW, Grabenhenrich LB, Nielsen RE, Berghöfer A, International Group for the Study of Lithium (IGSLi), et al. Kidney Int. 2014;86:857.
39. Mathew B, Rao JM, Sundari U. Lithium-induced changes in the body mass index. Acta Psychiatr Scand. 1989;80:538–40.
40. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379(9817):721-728
41. Minay J, Paul R, McGarvey D, Savage G, Stevenson M, Fogarty D, et al. Lithium usage and renal function testing in a large UK community population; a case-control study. Gen Hosp Psychiatry. 2013;35:631–5.
42. Müller-Oerlinghausen B, Bauer M, Grof P. Commentary on a recent review of lithium toxicity: what are its implications for clinical practice? BMC Med. 2012;10:132.
43. Oliveira JL, Silva Júnior GB, Abreu KL, Rocha Nde A, Franco LF, et al. Lithium nephrotoxicity. Rev Assoc Med Bras. 2010;56:600–6.
44. Paul R, Minay J, Cardwell C, Fogarty D, Kelly C. Meta-analysis of effects of lithium usage on serum creatinine levels. J Psychopharmacol. 2010;24:1425–31.
45. Pottegård A, Hallas J, Jensen BL, Madsen K, Friis S. Long-term lithium use and risk of renal and upper urinary tract cancers. J Am Soc Nephrol. 2016;27:249–55.
46. Rej S, Herrmann N, Shulman K. Effects of lithium on renal function in older adults: systematic review. J Geriatr Psychiatry Neurol. 2012;25:51–61.
47. Rej S, Pira S, Marshe V, Do A, Elie D, Looper KJ, et al. Molecular mechanisms in lithium-associated renal disease: a systematic review. Int Urol Nephrol. 2016;48:1843–53.
48. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, Cosio FG, Larson TS. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis. 2004;43:112–9.
49. Rybakowski JK, Abramowicz M, Drogowska J, Chłopocka-Woźniak M, Michalak M, Czkalski S. Screening for the markers of kidney damage in men and women on long-term lithium treatment. Med Sci Monit. 2012;18:CR656–60.
50. Schou M, Amdisen A, Thomsen K, Vestergaard P, Hetmar O, Mellerup ET, Plenge P, Rafaelsen OJ. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology. 1982;77:387–90.
51. Severus E, Bauer M. Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders. BMC Med. 2013;11:34.
52. Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15.
53. Shah JH, Pishdad G. The effect of lithium on glucose- and tolbutamide-induced insulin release and glucose tolerance in the intact rat. Endocrinology. 1980;107:1300–4.
54. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386:461–8.
55. Slaughter A, Pandey T, Jambhekar K. MRI findings in chronic lithium nephropathy: a case report. J Radiol Case Rep. 2010;4:15–21.
56. Stevens PE (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825-830
57. Tabata I, Schluter J, Gulve EA, Holloszy JO. Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes. 1994;43:903–7.
58. Tuazon J, Casalino D, Syed E, Batlle D. Lithium-associated kidney microcysts. Sci World J. 2008;8:828–9.
59. Turan T, Eşel E, Tokgöz B, Aslan S, Sofuoğlu S, Utaş C, Keleştimur F. Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:561–5.
60. Van Beneden K, Geers C, Pauwels M, Mannaerts I, Verbeelen D, van Grunsven LA, Van den Branden C. Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:1863–75.
61. Weinstein JR, Anderson S (2010) The aging kidney: physiological changes. Adv Chronic Kidney Dis 17(4):302-307
62. Zaidan M, Stucker F, Stengel B, Vasiliu V, Hummel A, Landais P, et al. Increased risk of solid renal tumors in lithium-treated patients. Kidney Int. 2014;86:184–90.